{"transactions":[{"id":1856966,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2023-06-14T01:20:24.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":141539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F4","text":"Represents the corrected number of securities owned due to a computational error in prior Form-4s"}],"balance_after":535051,"derivative":{"exercise_price":8.39,"expiration_date":"2030-06-08","underlying":"Common Stock","underlying_shares":141539},"source":{"system":"sec-edgar","filing":"0001367644-23-000119","document":"wk-form4_1686705615.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000119/wk-form4_1686705615.xml","form_type":"4"}},{"id":1856965,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-14T01:20:24.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":141539,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to both cumulative revenues and adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":506059,"source":{"system":"sec-edgar","filing":"0001367644-23-000119","document":"wk-form4_1686705615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000119/wk-form4_1686705615.xml","form_type":"4"}},{"id":1856964,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-06-14T01:20:24.000Z","date":"2023-06-09","kind":"grant","planned":false,"acquired":true,"shares":70769,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan.  These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company or the day prior to the annual shareholder meeting; whichever is earlier. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":364520,"source":{"system":"sec-edgar","filing":"0001367644-23-000119","document":"wk-form4_1686705615.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000119/wk-form4_1686705615.xml","form_type":"4"}},{"id":1968533,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2023-03-07T00:37:08.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":38462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the corrected number of securities owned due to a computational error on prior Form-4."}],"balance_after":258182,"derivative":{"exercise_price":12.06,"expiration_date":"2030-03-01","underlying":"Common Stock","underlying_shares":38462},"source":{"system":"sec-edgar","filing":"0001367644-23-000071","document":"wf-form4_167814941740129.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000071/wf-form4_167814941740129.xml","form_type":"4"}},{"id":1968532,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-07T00:37:08.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":38462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2023 and ending December 31, 2025, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the corrected number of securities owned due to a computational error on prior Form-4."}],"balance_after":293751,"source":{"system":"sec-edgar","filing":"0001367644-23-000071","document":"wf-form4_167814941740129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000071/wf-form4_167814941740129.xml","form_type":"4"}},{"id":1968531,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-07T00:37:08.000Z","date":"2023-03-02","kind":"grant","acquired":true,"shares":19231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Represents the corrected number of securities owned due to a computational error on prior Form-4."}],"balance_after":255289,"source":{"system":"sec-edgar","filing":"0001367644-23-000071","document":"wf-form4_167814941740129.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000071/wf-form4_167814941740129.xml","form_type":"4"}},{"id":1978872,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-03-02T19:42:04.000Z","date":"2023-02-28","kind":"tax_withholding","acquired":false,"shares":3226,"price":12.38,"value":39937.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":103298,"source":{"system":"sec-edgar","filing":"0001367644-23-000055","document":"wf-form4_167778610693108.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000055/wf-form4_167778610693108.xml","form_type":"4"}},{"id":1989843,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-28T01:22:02.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":1591,"price":13.71,"value":21812.61,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":106524,"source":{"system":"sec-edgar","filing":"0001367644-23-000032","document":"wf-form4_167754730066296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000032/wf-form4_167754730066296.xml","form_type":"4"}},{"id":1989842,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-28T01:22:02.000Z","date":"2023-02-23","kind":"tax_withholding","acquired":false,"shares":1428,"price":14.3,"value":20420.4,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":108115,"source":{"system":"sec-edgar","filing":"0001367644-23-000032","document":"wf-form4_167754730066296.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000032/wf-form4_167754730066296.xml","form_type":"4"}},{"id":2022352,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-11T01:36:09.000Z","date":"2023-02-08","kind":"tax_withholding","acquired":false,"shares":4944,"price":13.25,"value":65508.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":109543,"source":{"system":"sec-edgar","filing":"0001367644-23-000017","document":"wf-form4_167607935092887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000017/wf-form4_167607935092887.xml","form_type":"4"}},{"id":2022351,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2023-02-11T01:36:09.000Z","date":"2023-02-08","kind":"grant","acquired":true,"shares":278,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2022 fiscal year, as certified by the Compensation Committee following the performance period. On February 08, 2023, the final certification date, the Compensation Committee certified the achievement of the 2020-2022 PSUs at a payout factor of 101.67% of target resulting in the actual award of 16,961 shares of common stock, which is in excess of the 16,683 shares previously reported on February 25, 2020."}],"balance_after":114487,"source":{"system":"sec-edgar","filing":"0001367644-23-000017","document":"wf-form4_167607935092887.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764423000017/wf-form4_167607935092887.xml","form_type":"4"}},{"id":2359779,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2022-03-03T00:25:49.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":135330,"price":41.38,"value":5599955.4,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":135330,"derivative":{"exercise_price":41.38,"expiration_date":"2029-02-28","underlying":"Common Stock","underlying_shares":135330},"source":{"system":"sec-edgar","filing":"0001367644-22-000044","document":"wf-form4_164626713300332.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000044/wf-form4_164626713300332.xml","form_type":"4"}},{"id":2359778,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T00:25:49.000Z","date":"2022-02-28","kind":"tax_withholding","acquired":false,"shares":1715,"price":39.64,"value":67982.6,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":246969,"source":{"system":"sec-edgar","filing":"0001367644-22-000044","document":"wf-form4_164626713300332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000044/wf-form4_164626713300332.xml","form_type":"4"}},{"id":2359777,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T00:25:49.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":55582,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue calculated on a cumulative basis over the three-year period beginning January 1, 2022 and ending December 31, 2024, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":248684,"source":{"system":"sec-edgar","filing":"0001367644-22-000044","document":"wf-form4_164626713300332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000044/wf-form4_164626713300332.xml","form_type":"4"}},{"id":2359776,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-03-03T00:25:49.000Z","date":"2022-03-01","kind":"grant","acquired":true,"shares":33833,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":193102,"source":{"system":"sec-edgar","filing":"0001367644-22-000044","document":"wf-form4_164626713300332.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000044/wf-form4_164626713300332.xml","form_type":"4"}},{"id":2371532,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-25T22:18:00.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":2034,"price":42.47,"value":86383.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":159269,"source":{"system":"sec-edgar","filing":"0001367644-22-000031","document":"wf-form4_164582744695738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000031/wf-form4_164582744695738.xml","form_type":"4"}},{"id":2371531,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-25T22:18:00.000Z","date":"2022-02-23","kind":"tax_withholding","acquired":false,"shares":1419,"price":42.23,"value":59924.37,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld by the Company in exchange for payment of the employee's withholding taxes."}],"balance_after":161303,"source":{"system":"sec-edgar","filing":"0001367644-22-000031","document":"wf-form4_164582744695738.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000031/wf-form4_164582744695738.xml","form_type":"4"}},{"id":2374235,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-24T23:56:56.000Z","date":"2022-02-22","kind":"tax_withholding","acquired":false,"shares":4595,"price":42.23,"value":194046.85,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":162722,"source":{"system":"sec-edgar","filing":"0001367644-22-000022","document":"wf-form4_164574700044851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000022/wf-form4_164574700044851.xml","form_type":"4"}},{"id":2374234,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2022-02-24T23:56:56.000Z","date":"2022-02-22","kind":"grant","acquired":true,"shares":4264,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period. On February 22, 2022, the final certification date, the Compensation Committee certified the achievement of the 2019-2021 PSUs at a payout factor of 136.14% of target resulting in the actual award of 16,065 shares of common stock, which is in excess of the 11,801 shares previously reported on February 28, 2019."}],"balance_after":167317,"source":{"system":"sec-edgar","filing":"0001367644-22-000022","document":"wf-form4_164574700044851.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764422000022/wf-form4_164574700044851.xml","form_type":"4"}},{"id":2718229,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-05-11T20:25:14.000Z","date":"2021-05-08","kind":"tax_withholding","acquired":false,"shares":94,"price":61.62,"value":5792.28,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon vest of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":163053,"source":{"system":"sec-edgar","filing":"0001367644-21-000077","document":"wf-form4_162076469265250.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000077/wf-form4_162076469265250.xml","form_type":"4"}},{"id":2829169,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-26T22:17:35.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":59898,"price":93.49,"value":5599864.02,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":59898,"derivative":{"exercise_price":93.49,"expiration_date":"2028-02-23","underlying":"Common Stock","underlying_shares":59898},"source":{"system":"sec-edgar","filing":"0001367644-21-000046","document":"wf-form4_161437780493924.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000046/wf-form4_161437780493924.xml","form_type":"4"}},{"id":2829168,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-26T22:17:35.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":860,"price":97.15,"value":83549.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":163147,"source":{"system":"sec-edgar","filing":"0001367644-21-000046","document":"wf-form4_161437780493924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000046/wf-form4_161437780493924.xml","form_type":"4"}},{"id":2829167,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-26T22:17:35.000Z","date":"2021-02-26","kind":"tax_withholding","acquired":false,"shares":1716,"price":97.15,"value":166709.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":164007,"source":{"system":"sec-edgar","filing":"0001367644-21-000046","document":"wf-form4_161437780493924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000046/wf-form4_161437780493924.xml","form_type":"4"}},{"id":2829166,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-26T22:17:35.000Z","date":"2021-02-24","kind":"tax_withholding","acquired":false,"shares":2425,"price":93.49,"value":226713.25,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Represents shares of common stock withheld to pay taxes."}],"balance_after":165723,"source":{"system":"sec-edgar","filing":"0001367644-21-000046","document":"wf-form4_161437780493924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000046/wf-form4_161437780493924.xml","form_type":"4"}},{"id":2829165,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-26T22:17:35.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":14975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA margin calculated on a cumulative basis over the three-year period beginning January 1, 2021 and ending December 31, 2023, as certified by the Compensation Committee following the performance period.  The amount reported is based on the target performance payout factor, or 100%."}],"balance_after":168148,"source":{"system":"sec-edgar","filing":"0001367644-21-000046","document":"wf-form4_161437780493924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000046/wf-form4_161437780493924.xml","form_type":"4"}},{"id":2829164,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-26T22:17:35.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":14975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of restricted stock units granted under the company's Stock Incentive Plan. These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":153173,"source":{"system":"sec-edgar","filing":"0001367644-21-000046","document":"wf-form4_161437780493924.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000046/wf-form4_161437780493924.xml","form_type":"4"}},{"id":2866121,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-12T02:23:20.000Z","date":"2021-02-09","kind":"tax_withholding","acquired":false,"shares":423,"price":123.45,"value":52219.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs."}],"balance_after":138198,"source":{"system":"sec-edgar","filing":"0001367644-21-000016","document":"wf-form4_161309658433305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000016/wf-form4_161309658433305.xml","form_type":"4"}},{"id":2866120,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-12T02:23:20.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":323,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of PSUs previously granted on May 8, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year,as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 969 shares of common stock, which is in excess of the 646 shares previously reported on May 10, 2018."},{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of PSUs previously granted on May 8, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year,as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 969 shares of common stock, which is in excess of the 646 shares previously reported on May 10, 2018."}],"balance_after":138621,"source":{"system":"sec-edgar","filing":"0001367644-21-000016","document":"wf-form4_161309658433305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000016/wf-form4_161309658433305.xml","form_type":"4"}},{"id":2866119,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-12T02:23:20.000Z","date":"2021-02-09","kind":"tax_withholding","acquired":false,"shares":3870,"price":123.45,"value":477751.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents shares of common stock withheld to pay taxes due upon vesting of the PSUs."}],"balance_after":138298,"source":{"system":"sec-edgar","filing":"0001367644-21-000016","document":"wf-form4_161309658433305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000016/wf-form4_161309658433305.xml","form_type":"4"}},{"id":2866118,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-12T02:23:20.000Z","date":"2021-02-09","kind":"grant","acquired":true,"shares":2958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of Performance Stock Units (\"PSUs\") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 8,875 shares of common stock, which is in excess of the 5,917 shares previously reported on March 1, 2018."},{"field":"shares","element":"transactionShares","label":"F1","text":"Consists of Performance Stock Units (\"PSUs\") previously granted on February 27, 2018 under the company's stock incentive plan as amended and restated. Each PSU represents the right to receive one share of common stock, which vested at a specified percentage based upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2020 fiscal year, as certified by the Compensation Committee following the performance period. On February 9, 2021, the Compensation Committee certified the achievement of the 2018-2020 PSUs at a payout factor of 150% of target resulting in the actual award of 8,875 shares of common stock, which is in excess of the 5,917 shares previously reported on March 1, 2018."}],"balance_after":142168,"source":{"system":"sec-edgar","filing":"0001367644-21-000016","document":"wf-form4_161309658433305.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000016/wf-form4_161309658433305.xml","form_type":"4"}},{"id":2871372,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-09T22:23:57.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":13000,"price":120.03,"value":1560390.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted on 2/28/2017 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.19."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":19638,"derivative":{"exercise_price":30.63,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":13000},"source":{"system":"sec-edgar","filing":"0001367644-21-000008","document":"wf-form4_161290942063298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000008/wf-form4_161290942063298.xml","form_type":"4"}},{"id":2871371,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-02-09T22:23:57.000Z","date":"2021-02-08","kind":"exercise","acquired":false,"shares":32397,"price":120.03,"value":3888611.91,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 3/1/2016 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.20."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":30.86,"expiration_date":"2023-02-28","underlying":"Common Stock","underlying_shares":32397},"source":{"system":"sec-edgar","filing":"0001367644-21-000008","document":"wf-form4_161290942063298.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000008/wf-form4_161290942063298.xml","form_type":"4"}},{"id":2871370,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-09T22:23:57.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":13000,"price":120.03,"value":1560390.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted on 2/28/2017 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.19."}],"balance_after":139210,"source":{"system":"sec-edgar","filing":"0001367644-21-000008","document":"wf-form4_161290942063298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000008/wf-form4_161290942063298.xml","form_type":"4"}},{"id":2871369,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-09T22:23:57.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":13000,"price":30.63,"value":398190.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted on 2/28/2017 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."}],"balance_after":152210,"source":{"system":"sec-edgar","filing":"0001367644-21-000008","document":"wf-form4_161290942063298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000008/wf-form4_161290942063298.xml","form_type":"4"}},{"id":2871368,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-09T22:23:57.000Z","date":"2021-02-08","kind":"sale","acquired":false,"shares":32397,"price":120.03,"value":3888611.91,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 3/1/2016 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $120.00 to $120.20."}],"balance_after":139210,"source":{"system":"sec-edgar","filing":"0001367644-21-000008","document":"wf-form4_161290942063298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000008/wf-form4_161290942063298.xml","form_type":"4"}},{"id":2871367,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-02-09T22:23:57.000Z","date":"2021-02-08","kind":"exercise","acquired":true,"shares":32397,"price":30.86,"value":999771.42,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 3/1/2016 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."}],"balance_after":171607,"source":{"system":"sec-edgar","filing":"0001367644-21-000008","document":"wf-form4_161290942063298.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000008/wf-form4_161290942063298.xml","form_type":"4"}},{"id":2898895,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-01-22T21:14:28.000Z","date":"2021-01-21","kind":"exercise","acquired":false,"shares":21900,"price":110.03,"value":2409657.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $110.00 to $110.36."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":0,"derivative":{"exercise_price":26.45,"expiration_date":"2022-03-09","underlying":"Common Stock","underlying_shares":21900},"source":{"system":"sec-edgar","filing":"0001367644-21-000006","document":"wf-form4_161135005224162.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000006/wf-form4_161135005224162.xml","form_type":"4"}},{"id":2898894,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-01-22T21:14:28.000Z","date":"2021-01-20","kind":"exercise","acquired":false,"shares":2232,"price":110,"value":245520.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":21900,"derivative":{"exercise_price":26.45,"expiration_date":"2022-03-09","underlying":"Common Stock","underlying_shares":2232},"source":{"system":"sec-edgar","filing":"0001367644-21-000006","document":"wf-form4_161135005224162.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000006/wf-form4_161135005224162.xml","form_type":"4"}},{"id":2898893,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-22T21:14:28.000Z","date":"2021-01-21","kind":"sale","acquired":false,"shares":21900,"price":110.03,"value":2409657.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $110.00 to $110.36."}],"balance_after":139210,"source":{"system":"sec-edgar","filing":"0001367644-21-000006","document":"wf-form4_161135005224162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000006/wf-form4_161135005224162.xml","form_type":"4"}},{"id":2898892,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-22T21:14:28.000Z","date":"2021-01-21","kind":"exercise","acquired":true,"shares":21900,"price":26.45,"value":579255.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."}],"balance_after":161110,"source":{"system":"sec-edgar","filing":"0001367644-21-000006","document":"wf-form4_161135005224162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000006/wf-form4_161135005224162.xml","form_type":"4"}},{"id":2898891,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-22T21:14:28.000Z","date":"2021-01-20","kind":"sale","acquired":false,"shares":2232,"price":110,"value":245520.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."}],"balance_after":139210,"source":{"system":"sec-edgar","filing":"0001367644-21-000006","document":"wf-form4_161135005224162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000006/wf-form4_161135005224162.xml","form_type":"4"}},{"id":2898890,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-22T21:14:28.000Z","date":"2021-01-20","kind":"exercise","acquired":true,"shares":2232,"price":26.45,"value":59036.4,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."}],"balance_after":141442,"source":{"system":"sec-edgar","filing":"0001367644-21-000006","document":"wf-form4_161135005224162.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000006/wf-form4_161135005224162.xml","form_type":"4"}},{"id":2904006,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2021-01-19T21:28:42.000Z","date":"2021-01-15","kind":"exercise","acquired":false,"shares":19026,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Consists of an option granted on 03/11/2014 under the company's stock incentive plan as amended and restated."}],"balance_after":0,"derivative":{"exercise_price":25.62,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":19026},"source":{"system":"sec-edgar","filing":"0001367644-21-000004","document":"wf-form4_161109171024831.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000004/wf-form4_161109171024831.xml","form_type":"4"}},{"id":2904005,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-19T21:28:42.000Z","date":"2021-01-15","kind":"sale","acquired":false,"shares":19026,"price":106.0076,"value":2016900.5976,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 03/11/2014 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"The price reported is a weighted average sale price.  These shares were sold in multiple transactions at prices ranging from $104.52 to $107.79."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of derivative securities beneficially owned was adjusted to account for a change in previously reported PSUs. 8,163 PSUs were previously reported, of which only 5,169 vested on February 11, 2020."}],"balance_after":139210,"source":{"system":"sec-edgar","filing":"0001367644-21-000004","document":"wf-form4_161109171024831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000004/wf-form4_161109171024831.xml","form_type":"4"}},{"id":2904004,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2021-01-19T21:28:42.000Z","date":"2021-01-15","kind":"exercise","acquired":true,"shares":19026,"price":25.62,"value":487446.12,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of an option granted on 03/11/2014 under the company's stock incentive plan as amended and restated."},{"field":"kind","element":"transactionCoding","label":"F2","text":"All transactions listed on this Form 4 were made by the Reporting Person pursuant to a trading plan adopted on November 13, 2020 that is intended to comply with Rule 10b5-1(c) under the Securities Exchange Act of 1934, as amended (the \"Exchange Act\")."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F3","text":"The number of derivative securities beneficially owned was adjusted to account for a change in previously reported PSUs. 8,163 PSUs were previously reported, of which only 5,169 vested on February 11, 2020."}],"balance_after":158236,"source":{"system":"sec-edgar","filing":"0001367644-21-000004","document":"wf-form4_161109171024831.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764421000004/wf-form4_161109171024831.xml","form_type":"4"}},{"id":3152292,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-05-12T20:27:42.000Z","date":"2020-05-08","kind":"tax_withholding","acquired":false,"shares":95,"price":79.25,"value":7528.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":142203,"source":{"system":"sec-edgar","filing":"0001367644-20-000057","document":"wf-form4_158931524246734.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000057/wf-form4_158931524246734.xml","form_type":"4"}},{"id":3243393,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Employee Stock Options (Right to Buy)","published_at":"2020-02-28T02:17:34.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":66731,"price":61.44,"value":4099952.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company."}],"balance_after":113928,"derivative":{"exercise_price":61.44,"expiration_date":"2027-02-24","underlying":"Common Stock","underlying_shares":66731},"source":{"system":"sec-edgar","filing":"0001367644-20-000015","document":"wf-form4_158285623669698.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000015/wf-form4_158285623669698.xml","form_type":"4"}},{"id":3243392,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-28T02:17:34.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":1126,"price":59.91,"value":67458.66,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":142298,"source":{"system":"sec-edgar","filing":"0001367644-20-000015","document":"wf-form4_158285623669698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000015/wf-form4_158285623669698.xml","form_type":"4"}},{"id":3243391,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-28T02:17:34.000Z","date":"2020-02-27","kind":"tax_withholding","acquired":false,"shares":778,"price":58.42,"value":45450.76,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":143424,"source":{"system":"sec-edgar","filing":"0001367644-20-000015","document":"wf-form4_158285623669698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000015/wf-form4_158285623669698.xml","form_type":"4"}},{"id":3243390,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-28T02:17:34.000Z","date":"2020-02-26","kind":"tax_withholding","acquired":false,"shares":558,"price":59.91,"value":33429.78,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":144202,"source":{"system":"sec-edgar","filing":"0001367644-20-000015","document":"wf-form4_158285623669698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000015/wf-form4_158285623669698.xml","form_type":"4"}},{"id":3243389,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-28T02:17:34.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":16683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted EBITDA as a percentage of total GAAP revenue for the 2020 - 2022 fiscal years, as certified by the Compensation Committee following the performance period."}],"balance_after":144760,"source":{"system":"sec-edgar","filing":"0001367644-20-000015","document":"wf-form4_158285623669698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000015/wf-form4_158285623669698.xml","form_type":"4"}},{"id":3243388,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2020-02-28T02:17:34.000Z","date":"2020-02-25","kind":"grant","acquired":true,"shares":16683,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":128077,"source":{"system":"sec-edgar","filing":"0001367644-20-000015","document":"wf-form4_158285623669698.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000136764420000015/wf-form4_158285623669698.xml","form_type":"4"}},{"id":3531201,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2019-05-10T21:16:01.000Z","date":"2019-05-08","kind":"tax_withholding","acquired":false,"shares":95,"price":47.49,"value":4511.55,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":111394,"source":{"system":"sec-edgar","filing":"0001567619-19-010448","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919010448/doc1.xml","form_type":"4"}},{"id":3625803,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2019-03-01T00:35:59.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":47197,"price":61.01,"value":2879488.97,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments beginning on the day prior to the anniversary date of the grant."}],"balance_after":47197,"derivative":{"exercise_price":61.01,"expiration_date":"2026-02-25","underlying":"Common Stock","underlying_shares":47197},"source":{"system":"sec-edgar","filing":"0001567619-19-005678","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005678/doc1.xml","form_type":"4"}},{"id":3625802,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2019-03-01T00:35:59.000Z","date":"2019-02-28","kind":"tax_withholding","acquired":false,"shares":1941,"price":58.71,"value":113956.11,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":111489,"source":{"system":"sec-edgar","filing":"0001567619-19-005678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005678/doc1.xml","form_type":"4"}},{"id":3625801,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2019-03-01T00:35:59.000Z","date":"2019-02-27","kind":"tax_withholding","acquired":false,"shares":779,"price":57.98,"value":45166.42,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":113430,"source":{"system":"sec-edgar","filing":"0001567619-19-005678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005678/doc1.xml","form_type":"4"}},{"id":3625800,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2019-03-01T00:35:59.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":11801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Emergent BioSolutions Inc. Stock Incentive Plan.  Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to adjusted net income as a percentage of total GAAP revenue for the 2021 fiscal year, as certified by the Compensation Committee following the performance period."}],"balance_after":114209,"source":{"system":"sec-edgar","filing":"0001567619-19-005678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005678/doc1.xml","form_type":"4"}},{"id":3625799,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2019-03-01T00:35:59.000Z","date":"2019-02-26","kind":"grant","acquired":true,"shares":11801,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":102408,"source":{"system":"sec-edgar","filing":"0001567619-19-005678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005678/doc1.xml","form_type":"4"}},{"id":3625798,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2019-03-01T00:35:59.000Z","date":"2019-02-26","kind":"tax_withholding","acquired":false,"shares":565,"price":61.01,"value":34470.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the company's stock incentive plan, as amended and restated."}],"balance_after":90607,"source":{"system":"sec-edgar","filing":"0001567619-19-005678","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000156761919005678/doc1.xml","form_type":"4"}},{"id":3938470,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Employee Stock Option","published_at":"2018-05-10T20:37:18.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":2586,"price":48.33,"value":124981.38,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Vests on May 7, 2019; May 7, 2020 and May 7, 2021 in equal annual installments."}],"balance_after":2586,"derivative":{"exercise_price":48.33,"expiration_date":"2025-05-07","underlying":"Common Stock","underlying_shares":2586},"source":{"system":"sec-edgar","filing":"0001140361-18-022810","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118022810/doc1.xml","form_type":"4"}},{"id":3938469,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2018-05-10T20:37:18.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":646,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period."}],"balance_after":91172,"source":{"system":"sec-edgar","filing":"0001140361-18-022810","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118022810/doc1.xml","form_type":"4"}},{"id":3938468,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and COO"}}],"security":"Common Stock","published_at":"2018-05-10T20:37:18.000Z","date":"2018-05-08","kind":"grant","acquired":true,"shares":647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":90526,"source":{"system":"sec-edgar","filing":"0001140361-18-022810","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118022810/doc1.xml","form_type":"4"}},{"id":3997696,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Administration and CFO"}}],"security":"Common Stock","published_at":"2018-03-13T22:18:41.000Z","date":"2018-03-09","kind":"tax_withholding","acquired":false,"shares":1727,"price":51.84,"value":89527.68,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":89879,"source":{"system":"sec-edgar","filing":"0001140361-18-013320","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118013320/doc1.xml","form_type":"4"}},{"id":4023345,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Administration and CFO"}}],"security":"Employee Stock Option (right to buy)","published_at":"2018-03-01T22:04:23.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":23670,"price":49.64,"value":1174978.8,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Vests in three equal installments on February 26, 2019, February 26, 2020 and February 26, 2021."}],"balance_after":23670,"derivative":{"exercise_price":49.64,"expiration_date":"2025-02-26","underlying":"Common Stock","underlying_shares":23670},"source":{"system":"sec-edgar","filing":"0001140361-18-011288","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011288/doc1.xml","form_type":"4"}},{"id":4023344,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Administration and CFO"}}],"security":"Common Stock","published_at":"2018-03-01T22:04:23.000Z","date":"2018-02-28","kind":"tax_withholding","acquired":false,"shares":1545,"price":49.97,"value":77203.65,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":91606,"source":{"system":"sec-edgar","filing":"0001140361-18-011288","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011288/doc1.xml","form_type":"4"}},{"id":4023343,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Administration and CFO"}}],"security":"Common Stock","published_at":"2018-03-01T22:04:23.000Z","date":"2018-02-27","kind":"tax_withholding","acquired":false,"shares":778,"price":49.64,"value":38619.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":93151,"source":{"system":"sec-edgar","filing":"0001140361-18-011288","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011288/doc1.xml","form_type":"4"}},{"id":4023342,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Administration and CFO"}}],"security":"Common Stock","published_at":"2018-03-01T22:04:23.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":5917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F3","text":"Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2020 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period."}],"balance_after":93929,"source":{"system":"sec-edgar","filing":"0001140361-18-011288","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011288/doc1.xml","form_type":"4"}},{"id":4023341,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Administration and CFO"}}],"security":"Common Stock","published_at":"2018-03-01T22:04:23.000Z","date":"2018-02-27","kind":"grant","acquired":true,"shares":5917,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"shares","element":"transactionShares","label":"F2","text":"These restricted stock units vest in three equal annual installments beginning on the day prior to the first anniversary of the date of grant, assuming continued service with the company. Each restricted stock unit represents the right of the Reporting Person to receive one share of common stock of Emergent BioSolutions Inc., subject to adjustment as provided in the grant agreement."}],"balance_after":88012,"source":{"system":"sec-edgar","filing":"0001140361-18-011288","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036118011288/doc1.xml","form_type":"4"}},{"id":4390460,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Common Stock","published_at":"2017-03-11T02:30:39.000Z","date":"2017-03-10","kind":"tax_withholding","acquired":false,"shares":3007,"price":31.05,"value":93367.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":82095,"source":{"system":"sec-edgar","filing":"0001140361-17-011682","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117011682/doc1.xml","form_type":"4"}},{"id":4390459,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Common Stock","published_at":"2017-03-11T02:30:39.000Z","date":"2017-03-09","kind":"tax_withholding","acquired":false,"shares":1908,"price":30.98,"value":59109.84,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":85102,"source":{"system":"sec-edgar","filing":"0001140361-17-011682","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117011682/doc1.xml","form_type":"4"}},{"id":4408639,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-03-03T02:58:12.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":32638,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F8","text":"Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant."}],"balance_after":32638,"derivative":{"exercise_price":30.63,"expiration_date":"2024-02-27","underlying":"Common Stock","underlying_shares":32638},"source":{"system":"sec-edgar","filing":"0001140361-17-010396","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010396/doc1.xml","form_type":"4"}},{"id":4408638,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-03-03T02:58:12.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":2847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F9","text":"Consists of an option granted on 03/01/2016 under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":32397,"derivative":{"exercise_price":30.86,"expiration_date":"2023-02-28","underlying":"Common Stock","underlying_shares":2847},"source":{"system":"sec-edgar","filing":"0001140361-17-010396","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010396/doc1.xml","form_type":"4"}},{"id":4408637,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-03-03T02:58:12.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":2121,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F8","text":"Consists of an option granted on 03/10/2015 under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The option grant vests in three equal installments on the day prior to the first, second and third anniversary dates of the grant."}],"balance_after":24132,"derivative":{"exercise_price":26.45,"expiration_date":"2022-03-09","underlying":"Common Stock","underlying_shares":2847},"source":{"system":"sec-edgar","filing":"0001140361-17-010396","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010396/doc1.xml","form_type":"4"}},{"id":4408636,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Employee Stock Option (Right to buy)","published_at":"2017-03-03T02:58:12.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":1672,"price":25.62,"value":42836.64,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"Consists of an option granted on 03/11/2014 under the company's stock incentive plan as amended and restated.  In connection with the spin-off on August 1, 2016, the reporting person received a grant of additional stock options as a result of an adjustment to preserve the pre-spin intrinsic value of an existing stock option grant. The adjustments included an adjustment to the stock option price of the grant."}],"balance_after":19026,"derivative":{"exercise_price":25.62,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":1672},"source":{"system":"sec-edgar","filing":"0001140361-17-010396","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010396/doc1.xml","form_type":"4"}},{"id":4408635,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Common Stock","published_at":"2017-03-03T02:58:12.000Z","date":"2017-02-28","kind":"tax_withholding","acquired":false,"shares":1799,"price":30.63,"value":55103.37,"ownership":{"direct":true},"balance_after":87010,"source":{"system":"sec-edgar","filing":"0001140361-17-010396","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010396/doc1.xml","form_type":"4"}},{"id":4408634,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Common Stock","published_at":"2017-03-03T02:58:12.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":8162,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Consists of performance stock units granted under the Amended and Restated 2006 Emergent BioSolutions Inc. Stock Incentive Plan, as amended. Each PSU represents a right to receive one share of common stock. The PSUs vest upon achievement with respect to net income as a percentage of total revenue for the 2019 fiscal year, each as determined in accordance with GAAP, as certified by the Compensation Committee following the performance period."}],"balance_after":88809,"source":{"system":"sec-edgar","filing":"0001140361-17-010396","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010396/doc1.xml","form_type":"4"}},{"id":4408633,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Common Stock","published_at":"2017-03-03T02:58:12.000Z","date":"2017-02-28","kind":"grant","acquired":true,"shares":8161,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."}],"balance_after":80647,"source":{"system":"sec-edgar","filing":"0001140361-17-010396","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010396/doc1.xml","form_type":"4"}},{"id":4408632,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Common Stock","published_at":"2017-03-03T02:58:12.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":1425,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as\na result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in March 2017, March 2018 and March 2019."}],"balance_after":72486,"source":{"system":"sec-edgar","filing":"0001140361-17-010396","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010396/doc1.xml","form_type":"4"}},{"id":4408631,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Common Stock","published_at":"2017-03-03T02:58:12.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":1061,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as\na result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in March 2017 and March 2018."}],"balance_after":71061,"source":{"system":"sec-edgar","filing":"0001140361-17-010396","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010396/doc1.xml","form_type":"4"}},{"id":4408630,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corproate Services Div"}}],"security":"Common Stock","published_at":"2017-03-03T02:58:12.000Z","date":"2016-08-01","kind":"other","acquired":true,"shares":1672,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"In connection with the spin-off of Aptevo Therapeutics Inc. from Emergent BioSolutions Inc, on August 1, 2016 the reporting person received a grant of restricted stock units as\na result of an adjustment to an existing Emergent restricted stock unit grant held by the reporting person prior to the spin-off. The restricted stock units vest in March 2017."}],"balance_after":70000,"source":{"system":"sec-edgar","filing":"0001140361-17-010396","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117010396/doc1.xml","form_type":"4"}},{"id":4424136,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Stock Option","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"exercise","acquired":true,"shares":5503,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Consists of an option granted under the company's stock incentive plan on March 10, 2015."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F17","text":"The option vest in three equal installments in March 2016, 2017 and 2018."}],"balance_after":27514,"derivative":{"exercise_price":29,"expiration_date":"2022-03-09","underlying":"Common Stock","underlying_shares":5503},"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":15,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424135,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Stock Option","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"exercise","acquired":true,"shares":17354,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted under the company's stock incentive plan on March 11, 2014."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F16","text":"The option vest in three equal installments in March 2015, 2016 and 2017."}],"balance_after":34708,"derivative":{"exercise_price":28.09,"expiration_date":"2021-03-10","underlying":"Common Stock","underlying_shares":17354},"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":14,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424134,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Stock Option","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"exercise","acquired":true,"shares":3939,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan on March 12, 2013."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F15","text":"The option vest in three equal installments in March 2014, 2015 and 2016."}],"balance_after":3940,"derivative":{"exercise_price":14.67,"expiration_date":"2020-03-11","underlying":"Common Stock","underlying_shares":3939},"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":13,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424133,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Stock Option","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"exercise","acquired":true,"shares":11531,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan on November 5, 2012."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F14","text":"The option vested in three equal installments in November 2013, 2014 and 2015."}],"balance_after":11531,"derivative":{"exercise_price":14.41,"expiration_date":"2019-11-04","underlying":"Common Stock","underlying_shares":11531},"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":12,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424132,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"sale","acquired":false,"shares":2945,"price":35.73,"value":105224.85,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F13","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50 to $36.32, inclusive."}],"balance_after":74831,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424131,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"sale","acquired":false,"shares":1855,"price":35.8,"value":66409.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F12","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50 to $36.13, inclusive."}],"balance_after":77776,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424130,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"sale","acquired":false,"shares":445,"price":35.93,"value":15988.85,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F10","text":"Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F11","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.91 to $36.00, inclusive."}],"balance_after":79631,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424129,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"sale","acquired":false,"shares":5503,"price":35.66,"value":196236.98,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Consists of an option granted under the company's stock incentive plan on March 10, 2015."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F9","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.12 to $36.42, inclusive."}],"balance_after":80076,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424128,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"exercise","acquired":true,"shares":5503,"price":29,"value":159587.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F5","text":"Consists of an option granted under the company's stock incentive plan on March 10, 2015."}],"balance_after":85579,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424127,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"sale","acquired":false,"shares":17354,"price":35.48,"value":615719.92,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted under the company's stock incentive plan on March 11, 2014."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F8","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.07 to $36.35, inclusive."}],"balance_after":80076,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424126,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"exercise","acquired":true,"shares":17354,"price":28.09,"value":487473.86,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F4","text":"Consists of an option granted under the company's stock incentive plan on March 11, 2014."}],"balance_after":97430,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424125,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"sale","acquired":false,"shares":3939,"price":35.74,"value":140779.86,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan on March 12, 2013."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F7","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.37 to $36.32, inclusive."}],"balance_after":80076,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424124,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"exercise","acquired":true,"shares":3939,"price":14.67,"value":57785.13,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"Consists of an option granted under the company's stock incentive plan on March 12, 2013."}],"balance_after":84015,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424123,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"sale","acquired":false,"shares":11531,"price":35.49,"value":409235.19,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan on November 5, 2012."},{"field":"kind","element":"transactionCoding","label":"F1","text":"These sales were executed pursuant to a 10b5-1 trading plan adopted by the reporting person on February 29, 2016."},{"field":"price","element":"transactionPricePerShare","label":"F6","text":"The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.11 to $36.34, inclusive."}],"balance_after":80076,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}},{"id":4424122,"issuer":{"id":5902,"kind":"organization","name":"Emergent BioSolutions Inc.","symbol":"EBS"},"owners":[{"id":112374,"kind":"person","name":"Kramer Robert","position":1,"cik":"0001380956","reported_name":"Kramer Robert","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Corporate Services Divisi"}}],"security":"Common Stock","published_at":"2017-02-24T15:05:16.000Z","date":"2016-04-01","kind":"exercise","acquired":true,"shares":11531,"price":14.41,"value":166161.71,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Consists of an option granted under the company's stock incentive plan on November 5, 2012."}],"balance_after":91607,"source":{"system":"sec-edgar","filing":"0001140361-17-008973","document":"doc1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1367644/000114036117008973/doc1.xml","form_type":"4/A","original_submission_date":"2016-04-05"}}]}